Cardiovascular Benefits of Obesity Medication

In this penultimate episode of the video series that I recorded with ExchangeCME, I connect with Dr. Benjamin Scirica to explore the complex intersection of obesity and cardiovascular disease, with a focus on heart failure with preserved ejection fraction (HFpEF). Together, we examine the diagnostic challenges unique to patients with obesity, discuss the pathophysiologic drivers linking excess adiposity to cardiometabolic dysfunction, and review how glucagon-like peptide-1 (GLP-1) receptor agonists can be used to improve outcomes. https://bit.ly/PhoneAFriendEp9

About This Series:

In this educational video series Dr. Charles Vega and I collaborated and focused on obesity management in the GLP-1 receptor agonist era. Throughout the series, we explore common clinical challenges encountered in primary care and share practical, evidence-based approaches with insights from nationally recognized experts in obesity medicine. In this episode, I lead the discussion, and I encourage you to explore the other episodes in the series featuring Dr. Vega and additional experts in obesity medicine.

#Obesity #ObesityManagement #physician